All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.

More information on our cookie policy.

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
  • Special reports
    • Artificial intelligence
    • Coronavirus
    • IVDs on the rise
    • Top Biopharma Trends of 2021
    • Top Med-tech Trends of 2021
    • Premium reports
      • BioWorld Financings Reports
      • Disease Incidence & Prevalence Summaries

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, May 16, 2022
Home » Topics » Financings

Financings
Financings RSS Feed RSS

Financings for April 13, 2022

April 13, 2022
No Comments
Med-tech firms raising money in public or private financings, including: Affyxell Therapeutics, Avacta Group, Daewoong Pharmaceutical, Lyra Therapeutics, Versantis.
Read More

Financings for April 13, 2022

April 13, 2022
No Comments
Biopharmas raising money in public or private financings, including: Affimed, Aquestive, Blue Water, Crinetics, Liquidia, Lixte, Lyra, Navidea and NLS.
Read More

Financings for April 12, 2022

April 12, 2022
No Comments
Biopharmas in Asia-Pacific raising money in public or private financings: Rona.
Read More

Financings for April 12, 2022

April 12, 2022
No Comments
Med-tech firms raising money in public or private financings, including: Curie AI, Umeå Biotech Incubator.
Read More
European flag, vial, syringe

NEC Oncoimmunity bags $4.8M to develop vaccines for SARS-CoV-2 variants, other betacoronaviruses

April 12, 2022
By Gina Lee
No Comments
NEC Corp. subsidiary NEC Oncoimmunity AS recently received $4.8 million from the Coalition for Epidemic Preparedness Innovations to fund the development of vaccines for SARS-CoV-2 variants and other betacoronaviruses.
Read More

Biopharma financings in Q1 at lowest point since 2017

April 12, 2022
By Karen Carey
No Comments
Biopharma financings for the first quarter of 2022 are at a five-year low, with 65.8% less money and 53% fewer transactions than a year ago. The industry raised $13.1 billion through 249 financings, compared with $38.3 billion from 529 transactions in 2021.
Read More

Financings for April 12, 2022

April 12, 2022
No Comments
Biopharmas raising money in public or private financings, including: Bone, Carthronix, Celsion, Design, Eupraxia, Hoth, Kintara, Maia, Osmol, Pacira Polycore, Prilenia, Renexxion, Stealth, Turn.
Read More
Pharmaceutical manufacturing

NEC Oncoimmunity bags $4.8M to develop vaccines for SARS-CoV-2 variants, other betacoronaviruses

April 11, 2022
By Gina Lee
No Comments
NEC Corp. subsidiary NEC Oncoimmunity AS recently received $4.8 million from the Coalition for Epidemic Preparedness Innovations to fund the development of vaccines for SARS-CoV-2 variants and other betacoronaviruses.
Read More
Dollar sign and Euro symbol in cogwheels

Carlyle launches biotech financing effort via Abingworth acquisition

April 11, 2022
By Nuala Moran
No Comments
U.S. private equity group Carlyle is extending its reach into biotech financing through the acquisition of London-based venture capital firm Abingworth, with which it is forming Launch Therapeutics, an operating company that will fund and manage late-stage clinical development of programs sourced from pharma and biotech companies. The move will enable further scaling of the clinical co-development model Abingworth first devised in 2009.
Read More

Financings for April 11, 2022

April 11, 2022
No Comments
Med-tech firms raising money in public or private financings, including: Biodesix, Trinity Biotech.
Read More
Previous 1 2 … 5 6 7 8 9 10 11 12 13 … 291 292 Next

Popular Stories

  • Free access to BioWorld coronavirus articles

    BioWorld

    The articles in this collection are from BioWorld’s ongoing coverage of the COVID-19 coronavirus outbreak. Note that we have added three critical tables which are...

  • Today's news in brief

    BioWorld
    BioWorld briefs for May 13, 2022.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech's briefs for May 13.
  • Hearing ear icon

    Cochlear to acquire rival Oticon Medical for $121M

    BioWorld MedTech
    Cochlear Ltd. will acquire Danish hearing implant company Oticon Medical A/S for AU$170 million (US$121 million) after parent company the Demant Group said it...
  • Illustration of cancer cells and immunotherapy treatment

    Former Genentech execs launch new immunotherapy biotech LTZ Therapeutics

    BioWorld
    After raising $17 million in seed funding, immunotherapy-focused biotech company, LTZ Therapeutics Inc., is announcing plans for the fledgling company whose...
black cortellis ad

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Subscribe
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Archives
    • Today's news
    • Search BioWorld Science
    • About
  • More
    • About
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
Follow Us

Copyright ©2022. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing